Nuwellis Inc. (NUWE)
Company Description
Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy.
The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics.
Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter.
The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom.
The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021.
Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Country | United States |
IPO Date | Feb 16, 2012 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 59 |
CEO | John L. Erb |
Contact Details
Address: 12988 Valley View Road Eden Prairie, Minnesota United States | |
Website | https://www.nuwellis.com |
Stock Details
Ticker Symbol | NUWE |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001506492 |
CUSIP Number | 12542Q706 |
ISIN Number | US67113Y4052 |
Employer ID | 68-0533453 |
SIC Code | 3845 |
Key Executives
Name | Position |
---|---|
John L. Erb | Interim President, Interim Chief Executive Officer & Chairman of the Board |
Robert B. Scott | Chief Financial Officer |
Betsy Riemenschneider | Vice President of Sales |
Dr. John Lynn Jefferies FACC, M.B.A., M.D., M.P.H. | Chief Medical Officer & Member of Medical Advisory Board |
Neil P. Ayotte Esq. | Senior Vice President, General Counsel, Secretary & Chief Compliance Officer |
Paul Wotta | Corporate Controller |
Sandra Eayrs | Chief Human Resources Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Feb 24, 2025 | 8-K | Current Report |
Dec 20, 2024 | 424B3 | Filing |
Dec 19, 2024 | S-1/A | [Amend] Filing |
Dec 19, 2024 | 8-K | Current Report |
Dec 16, 2024 | 8-K | Current Report |
Nov 20, 2024 | D | Filing |
Nov 15, 2024 | S-1 | Filing |
Nov 12, 2024 | 10-Q | Quarterly Report |
Nov 12, 2024 | 8-K | Current Report |
Nov 07, 2024 | 8-K | Current Report |